Federal budget grants $1.8 billion to Alzheimer’s and dementia research

Congress has appropriated an additional $414 million for research into Alzheimer’s disease and other ...

ciTBI uncommon in minor head injuries with isolated vomiting

FROM PEDIATRICS Clinically important traumatic brain injury (ciTBI) is uncommon in children with minor ...

Frankincense extract may reduce disease activity in relapsing-remitting MS

FROM Journal of Neurology, Neurosurgery & Psychiatry A standardized frankincense extract was safe, well ...

Office-based screen predicts dementia in Parkinson’s disease

FROM JAMA NEUROLOGY A simple, office-based screening tool was at least as effective as ...

In utero exposure to valproate and other AEDs linked to low test scores

FROM THE JOURNAL OF NEUROLOGY, NEUROSURGERY & PSYCHIATRY In utero exposure to some antiepileptic ...

Siponimod trial ‘first’ to show delayed disability in secondary progressive MS

FROM THE LANCET Phase 3 data with siponimod, Novartis’ investigational treatment for multiple sclerosis, ...

FDA approves subcutaneous immunoglobulin treatment for CIDP

The Food and Drug Administration has approved Hizentra as the first subcutaneously administered human ...

MRI finds PML in some natalizumab-treated patients despite negative CSF, no symptoms

FROM JAMA NEUROLOGY Some multiple sclerosis patients who are treated with natalizumab can have ...

Early management of patients with acute ischemic stroke

Significant changes have occurred in the updated American Heart Association Stroke Council’s recommendations for ...